To evaluate the biological activity of AD-MSC-EVs, we used a disease-relevant in vitro model based on immortalized hepatic stellate cells (LX-2; Xu et al., 2005) activated with the pro-fibrogenic transforming growth factor (TGF)-β1. The gene discussed is TGFB1; the disease is Alzheimer disease.